Dallas, TX -- (SBWIRE) -- 05/26/2015 -- The report titled "Global Anti-Migraine Drugs Market: Trends and Opportunities (2014-2019)" provides an insight into migraine drugs with a special focus on Triptans. The report also includes the market value, segmentation, types of diagnosis and treatment for migraine. It also discusses key growth drivers and upcoming trends of the market. Further, key manufacturers of anti-migraine drugs like Endo International Inc, Imapc Laboratories, GlaxoSmithKline and Pfizer Inc. are profiled in the report.

Migraine, a condition of recurring headaches and is accompanied by symptoms like nausea, vomiting, dizziness and sensitivity to light and noise ranks among the World's Top 20 disabling medical illnesses. Complete report available at http://www.marketreportsonline.com/342258.html.

It is anticipated that launches of many generic migraine drugs over the next several years will steadily increase diagnosis and drug-treatment rates, leading to sustained annual global growth of anti-migraine drugs market. Other factors contributing to the growth of these drugs include awareness among the people about proper diagnosis and treatment of migraine, rise in medical expenditures and new drugs launches.

Acute migraine treatment market is dominant by Triptans and most of them are available as pills. Triptans like Sumatriptan and Zolmitriptan are also available as nasal sprays whereas rizatriptan and zolmitriptan are available as tablets that dissolve in mouth. In next 5-10 years, cost of migraine drugs is anticipated to decline due to many generic entrants as most of them are losing their patents. Growing awareness of migraine in the emerging countries and fall in prices will facilitate the growth of anti-migraine drugs market. In addition, with the development of new treatment therapies like calcitonin gene-related peptides (CGRP) receptor antagonist and BOTOX the demand for anti-migraine drugs is anticipated to grow further.

Purchase a copy of this research report at USD 800 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=342258.

The US is the largest market for anti-migraine drugs and there are number of companies that manufacture these drugs. Major companies include Impax, Endo Pharmaceuticals, Pfizer, GlaxoSmith Kline, Nautilus and Allergan.

Major points from Table of Contents:

1. Executive Summary
2. Migraine
3. Anti-Migraine Drugs Market
4. The US Migraine Market
5. Migraine Market: Drivers & Challenges
6. Migraine Market: Key Challenges
7. Migraine Market: Upcoming Trends
8. Migraine Market: Competitive Landscape
9. Migraine Market: Company Profiles
List of Tables
List of Figures

Other Related Reports on Pharmaceuticals Market:

Global Hemophilia Market Report: 2015 Edition (http://www.marketreportsonline.com/409838.html) Hemophilia is an inherited or acquired bleeding disorder that prevents blood from clotting. People with hemophilia lack, either partially or completely, an essential clotting factor needed to form stable blood clots. People with hemophilia do not bleed any faster than normal, but they can bleed for a longer time.

US Thyroid Cancer Market: Trends and Opportunities (2015 - 2019) (http://www.marketreportsonline.com/404148.html) Thyroid cancer, a type of malignant cancer, initiate from follicular and par follicular thyroid cells. The most effective treatment of thyroid cancer is surgical removal of thyroid gland followed by radioactive ablation and thyroid stimulating hormone (TSH) suppression therapy. Chemotherapy is also used in cases of metastasis and progressive stage of thyroid cancer.

About MarketReportsOnline
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Us:
Ritesh Tiwari
Corporate Office
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252.
Tel: 888-391-5441
E-mail: sales@marketreportsonline.com